Facephi Biometria, S.A. (BME:FACE)

Facephi Biometria Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-8.88	-4.31	1.11	-0.55
Depreciation & Amortization	0.55	0.65	0.16	0.08
Other Amortization	5.04	4.13	1.81	1.2
Loss (Gain) From Sale of Assets	-0	-0	-	-
Asset Writedown & Restructuring Costs	-	-	0	-
Loss (Gain) From Sale of Investments	-	-	0.8	0.38
Provision & Write-off of Bad Debts	0.42	1.27	0.72	0.08
Other Operating Activities	0.88	-1.61	-3.63	-0.81
Change in Accounts Receivable	-1.78	-5.45	-8.96	-4.83
Change in Accounts Payable	4.82	5.71	2.53	1.36
Change in Other Net Operating Assets	-0.33	0.46	-0.37	-0.51
Operating Cash Flow	0.72	0.85	-5.82	-3.6
Operating Cash Flow Growth	-15.09%	-	-	-
Capital Expenditures	-0.25	-1.52	-1.57	-0.3
Sale of Property, Plant & Equipment	0	-	0.03	-
Cash Acquisitions	-0.01	-	-	-0
Sale (Purchase) of Intangibles	-5	-8.34	-0.5	-2.25
Investment in Securities	-	-	-0.16	0.41
Other Investing Activities	-0.03	0.03	-	-0
Investing Cash Flow	-5.28	-9.83	-2.2	-2.14
Long-Term Debt Issued	-	5.24	1.6	-
Long-Term Debt Repaid	-1.55	-1.27	-0.01	-0.81
Net Debt Issued (Repaid)	-1.55	3.96	1.59	-0.81
Issuance of Common Stock	8.67	8.41	5.02	2.7
Repurchase of Common Stock	-0.38	-0.45	-0.34	-0.59
Other Financing Activities	0.82	-2.38	2.33	-0
Financing Cash Flow	7.56	9.54	8.6	1.3
Foreign Exchange Rate Adjustments	-	-0	-0.11	0.16
Miscellaneous Cash Flow Adjustments	-	-	-0	-
Net Cash Flow	3	0.56	0.47	-4.28
Free Cash Flow	0.48	-0.66	-7.39	-3.91
Free Cash Flow Margin	1.43%	-2.27%	-28.31%	-25.48%
Free Cash Flow Per Share	0.02	-0.03	-0.43	-0.26
Cash Interest Paid	1.52	0.81	0.28	0.4
Cash Income Tax Paid	-0.44	-	0	0.32
Levered Free Cash Flow	-8.09	-8.48	1.35	-4.62
Unlevered Free Cash Flow	-7.14	-7.41	1.54	-4.38
Change in Working Capital	2.71	0.73	-6.8	-3.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.